To include your compound in the COVID-19 Resource Center, submit it here.

Abbott submits Xinlay prostate cancer NDA

ABT submitted an NDA to the FDA

Read the full 70 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE